Results of logistic regression models for associations between patient characteristics and completion of chemotherapy
| Analysis of cases with complete data on patient factors (n=1291) | Analysis using all patients with known outcomes (n=1741) | ||
|---|---|---|---|
| Unadjusted OR | Adjusted OR* (95% CI) | Adjusted OR (95% CI)* | |
| Age | |||
| Under 55 | 1 | 1 | 1 |
| 55–64 | 0.89 | 0.89 (0.62 to 1.27) | 0.90 (0.66 to 1.23) |
| 65–74 | 0.71 | 0.75 (0.54 to 1.04) | 0.75 (0.55 to 1.01) |
| 75 and over | 0.53 | 0.64 (0.43 to 0.97) | 0.60 (0.43 to 0.84) |
| Gender | |||
| Female | 1 | 1 | 1 |
| Male | 0.94 | 1.01 (0.75 to 1.37) | 0.91 (0.72 to 1.14) |
| Index of multiple deprivation | |||
| 1 (least) | 1 | 1 | 1 |
| 2 | 0.91 | 0.96 (0.64 to 1.43) | 0.93 (0.69 to 1.25) |
| 3 | 0.75 | 0.71 (0.46 to 1.11) | 0.78 (0.58 to 1.05) |
| 4 | 0.74 | 0.72 (0.46 to 1.13) | 0.78 (0.57 to 1.07) |
| 5 (most) | 0.60 | 0.60 (0.40 to 0.90) | 0.66 (0.49 to 0.91) |
| Tumour | |||
| Oesophagus | 1 | 1 | 1 |
| Stomach | 1.05 | 1.08 (0.85 to 1.37) | 1.10 (0.89 to 1.36) |
| Diagnosis | |||
| Adenocarcinoma | 1 | 1 | 1 |
| Squamous cell | 0.85 | 0.85 (0.59 to 1.20) | 0.81 (0.59 to 1.11) |
| Other | 0.93 | 0.96 (0.54 to 1.70) | 0.97 (0.63 to 1.51) |
| Pretreatment stage | |||
| 1 or 2 | 1.17 | 1.58 (0.58 to 4.27) | 1.27 (0.67 to 2.39) |
| 3 | 1.01 | 1.20 (0.52 to 2.74) | 1.20 (0.83 to 1.73) |
| 4 | 1 | 1 | 1 |
| ECOG/WHO performance status | |||
| 0 no restrictions | 1 | 1 | 1 |
| 1 restricted in strenuous activities | 0.76 | 0.83 (0.62 to 1.10) | 0.75 (0.58 to 0.96) |
| 2 unable to work or worse | 0.31 | 0.37 (0.26 to 0.53) | 0.34 (0.25 to 0.46) |
| Comorbidities | |||
| None | 1 | 1 | 1 |
| 1 | 0.87 | 0.94 (0.71 to 1.25) | 0.94 (0.75 to 1.18) |
| 2 or more | 0.68 | 0.80 (0.53 to 1.20) | 0.78 (0.56 to 1.09) |
*Adjusted for the remaining variables.
ECOG, Eastern Cooperative Oncology Group.